Elicio Therapeutics News

JonesTrading Maintains Elicio Therapeutics(ELTX.US) With Buy Rating, Maintains Target Price $9

Futu NewsNov 15 00:31

JonesTrading Maintains Elicio Therapeutics(ELTX.US) With Buy Rating, Maintains Target Price $9

Futu NewsNov 9 02:31

JonesTrading Initiates Elicio Therapeutics(ELTX.US) With Buy Rating, Announces Target Price $9

Futu NewsOct 31 04:31

Elicio Therapeutics Analyst Ratings

BenzingaAug 23 20:07

HC Wainwright & Co. Reiterates Buy on Elicio Therapeutics, Maintains $10 Price Target

BenzingaAug 23 20:07

H.C. Wainwright Maintains Elicio Therapeutics(ELTX.US) With Buy Rating, Maintains Target Price $10

Futu NewsAug 23 18:33

Elicio Therapeutics Analyst Ratings

BenzingaJun 6 18:50

HC Wainwright & Co. Reiterates Buy on Elicio Therapeutics, Maintains $10 Price Target

BenzingaJun 6 18:50

Elicio Therapeutics Analyst Ratings

BenzingaMay 22 18:40

HC Wainwright & Co. Reiterates Buy on Elicio Therapeutics, Maintains $10 Price Target

BenzingaMay 22 18:40

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ionis Pharmaceuticals (IONS) and Elicio Therapeutics (ELTX)

TipRanksMay 17 20:05

HC Wainwright & Co. Maintains Buy on Elicio Therapeutics, Lowers Price Target to $10

BenzingaMay 1 18:30

HC Wainwright & Co. : The Elicio Therapeutics (ELTX.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $11.00 to $10.00.

Zhitong FinanceMay 1 18:20

Elicio Therapeutics Analyst Ratings

BenzingaMay 1 18:20

Elicio Therapeutics Analyst Ratings

BenzingaApr 1 21:25

HC Wainwright & Co. Maintains Buy on Elicio Therapeutics, Raises Price Target to $11

BenzingaJan 17 19:25

Elicio Therapeutics Analyst Ratings

BenzingaJan 17 19:23

Buy Rating Upheld for Elicio Therapeutics Amid Solid Financial Position and Promising Clinical Results

TipRanksNov 13, 2023 19:18

Elicio Therapeutics Analyst Ratings

BenzingaOct 26, 2023 20:23